INDV Share PerformanceMore
|52 week high||382.30 17/02/17|
|52 week low||266.60 15/12/16|
|52 week change||42.30 (15.43%)|
|4 week volume||24,248,558 27/06/17|
Latest News« previous» nextMore
13/07/2017 - 14:11 StockMarketWire
Indivior has confirmed that the Company intends to release its half year 2017 results on 27 July. At 2:11pm: (LON:INDV) In...
13/07/2017 - 14:00 RNS
RNS Number: 8369K Indivior PLC 13 July 2017 Indivior to Announce Half Year 2017 Results on July 27 th Slough, UK, and Richmond, VA, July 13th 2017 - Indivior PLC (LON: INDV) today announced that it will release its half year 2017 results on July 27 th at 7:00 a.m. London time (2:00 a.m. U.S. EDT). The results will be available via the London Stock Exchange's R...
29/06/2017 - 11:00 RNS
RNS Number: 5703J Indivior PLC 29 June 2017 Indivior to Host Investor Event Today on RBP-6000 at 12:00 Noon EDT US (5:00 P.M. UK Time) Slough, UK, and Richmond, VA, June 29th, 2017 - Indivior PLC (LON: INDV) today will host an investor presentation on RBP-6000, its once monthly injectable buprenorphine which is being developed for the treatment of m...
16/06/2017 - 14:00 RNS
RNS Number: 2638I Indivior PLC 16 June 2017 Indivior to Host Investor Event on RBP-6000 on June 29that 12:00 Noon EDT US (5:00 P.M. UK Time) Slough, UK, and Richmond, VA, June 16th, 2017 - Indivior PLC (LON: INDV) today announced that it will host an investor presentation on RBP-6000, its once monthly injectable buprenorphine which is being developed ...
02/06/2017 - 09:25 RNS
RNS Number: 9854G Indivior PLC 02 June 2017 BLOCK LISTING SIX MONTHLY RETURN Date: June 2, 2017 Name of applicant: INDIVIOR PLC Name of scheme: U.S. EMPLOYEE STOCK PURCHASE PLAN Period of return: From: DECEMBER 2, 2016 To: JUNE 1, 2017 Balance of unallotted securities under scheme(s) from previous return: 1,500,000 ORDINAR...
01/06/2017 - 15:16 RNS
RNS Number: 9092G Indivior PLC 01 June 2017 Indivior PLC - Total Voting Rights and Capital In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, Indivior PLC (the 'Company') hereby notifies the market that as at June 1, 2017 the Company's issued share capital consisted of 720,988,383 O rdinary Shares of US$0.10 each. The Company does n...
30/05/2017 - 16:24 RNS
RNS Number: 6059G Indivior PLC 30 May 2017 Indivior Submits New Drug Application to U.S. FDA for RBP-6000 Buprenorphine Monthly Depot A Potential Novel Long-Acting, Sustained-Release Product Candidate for Treatment of Opioid Use Disorder Slough, UK, 30 May 2017 - Indivior PLC (LON: INDV) (the 'Company') today announced that the Company has ...
23/05/2017 - 17:00 RNS
RNS Number: 9881F Indivior PLC 23 May 2017 Indivior's Shaun Thaxter to present at the Jefferies Global Healthcare Conference on June 6th Slough, UK, May 23rd, 2017 - Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will present at the Jefferies Global Healthcare Conference on June 6th, 2017, at 10:00 a.m. local time, in New York City. Mark...
Latest discussion posts More
“The FT quotes: "If Indivior can navigate these legal risks while keeping market share steady, ?it could become a target for a larger peer,? RBC said in a recent note. RBC named ...”▼
“"With the fatal South Korean disinfectant scandal, tough Russian market and sluggish take-up of Scholl footwear products, LSE:RB.:Reckitt Benckiser missed City forecasts in the ...”▼
“The Telegraph's Questor again showed his form in advising to sell these at #1.70 a couple of months ago, and now they are #3.42. The RB-6000 drug had good results in its ...”▼
Codes & Symbols
|Symbols||INDV, LSE:INDV, INDV.L, INDV:LN, LON:INDV, XLON:INDV|